Agein Corporation, a Leading Anti-Aging Company, Announces the Launch of Its Web Site, Agein.com

Posted on by

Boston, MA (PRWEB) August 01, 2013

Agein.com, the Internets premier anti-aging web site focusing on anti-aging tips, news, and advice from some of the foremost experts in the industry, was officially launched today by Agein Corporation.

Agein.com provides information on all of the latest advances in anti-aging research, the hottest anti-aging trends in Hollywood, and beauty tips from Laura Foreman, Agein.com's expert Anti-Aging Life Coach. The site is especially useful to those who want the full spectrum of anti-aging advice that cuts through the myths and provides expert, well-researched and useful tips and advice.

Agein.com is the Internets most comprehensive source for anti-aging tips, anti-aging news and anti-aging research and advice. At Agein.com, our goal is to inspire our readers to adapt an anti-aging lifestyle that suits their individual needs, says Foreman, who has spent 18 years working in the high-end beauty, skincare, and cosmetics industry. Our anti-aging experts share their industry leading insight on diet, fitness, and skin care and how all of these areas affect the way we look and feel.

Agein.com has some of the most seasoned anti-aging experts in the industry. In addition to Foreman, Agein.coms anti-aging life coach, there is Dr. K.J. McLaughlin, who has degrees in nutrition and physical education and 27 years of clinical experience, and is a certified strength and conditioning specialist with an interest in anti-aging medicine.

As Agein.coms Executive Content Editor, Soriyya Bawa brings a wealth of both academic and practical experience to Agein, having spent several years writing beauty and anti-aging advice for an international fashion and lifestyle magazine.

Marni Andrews has done extensive research in the area of healthy living and longevity, and has written a wide range of material on anti-aging, health, and wellness.

Samira Zia Rehman is a beauty advisor and writer who is certified by the Canadian Cosmetic Careers Association, and has been working since 2007 as a cosmetician and skin care specialist at one of Canadas leading drugstores. Samira has built a solid reputation in the beauty industry through her breadth of knowledge and honest recommendations.

To learn more about Agein Corporation, visit the companys web site at http://www.Agein.com.

About Agein.com: Agein.com's goal is to provide the latest anti-aging breakthroughs and advice in an easy-to-read format that gives readers the real, useful techniques to help maintain a youthful appearance. Agein.com's anti-aging experts specialize in diet, fitness, beauty and skin care, and how all of these areas affect the way people look and feel. Agein.com also provides information on all of the latest advances in anti-aging research, the hottest anti-aging trends in Hollywood, and beauty tips from Laura Foreman, Anti-Aging Life Coach.

See the original post here:
Agein Corporation, a Leading Anti-Aging Company, Announces the Launch of Its Web Site, Agein.com

Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments – Video

Posted on by


Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments. Telecast on 23/6/2013 Stem Cell Therapy done at Dr Alok Sharma Ne...

By: Neurogen Brain and Spine Institute

Link:
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments - Video

Stem Cell Therapy – Amazing Breakthrough in Skin wrinkles treatment – Video

Posted on by


Stem Cell Therapy - Amazing Breakthrough in Skin wrinkles treatment
Stem Cell Therapy is the newest bio-active topical cream that actually stimulates your own existing skin stem cells to grow smooth, supple, firm new skin. Fo...

By: Buystemcell.com.au

Read more from the original source:
Stem Cell Therapy - Amazing Breakthrough in Skin wrinkles treatment - Video

Siemens Shows Labs How to “Test Smarter. Run Faster.” at AACC 2013

Posted on by

HOUSTON--(BUSINESS WIRE)--

Siemens Healthcare Diagnostics is showcasing its latest innovations that unite clinical and workflow excellence to help laboratories Test smarter. Run faster. at the 2013 AACC and ASCLS Annual Meeting and Clinical Lab Expo in Houston, July 28 August 1 (Booth #3449). This years exhibit visually recreates the various clinical environments in which Siemens proven solutions can be found, including the central, microbiology, and molecular lab, emergency department, intensive care unit (ICU) and physicians office/clinic.

Whether conducted in a lab, a doctors office or even at a patients bedside, clinical diagnostic testing will continue to increase in importance for optimizing patient care, especially in light of increasing pressure on healthcare systems, said Michael Reitermann, CEO, Siemens Healthcare Diagnostics. At this years AACC, Siemens is proud to demonstrate how we are leveraging our scientific, technological and business acumen to meet our customers needs from a workflow and clinical perspective.

Central Laboratory Solutions

Siemens AACC 2013 presence once again highlights the companys pioneering advances in central laboratory automation, including the unveiling of the VersaCellX3 Solution1, a unique sample management solution for low and medium volume labs that increases flexibility and advances workflow capabilities for up to three connected Siemens analyzers. Using advanced robotics with dynamic STAT management for the optimal mix of chemistry and/or immunoassay analytics along with one-touch sample management, the VersaCell X3 Solution enables labs to streamline a non-automated environment without the resource requirements of track-based automation. For the higher volume market, the Siemens Aptio Automation1 unified solution helps address the changing workload and expanding needs of todays growing clinical laboratory, while delivering innovation for better patient care.

Leadership in the central lab innovation extends to Siemens IT platforms, including the CentraLink Data Management System1, which displays clinical data and manages workflow across multiple disciplines and platforms, including the VersaCell X3 Solution and Aptio Automation. Attendees are also learning how the new syngo Lab Inventory Manager2 leverages cloud-based technology to streamline and automate the inventory management process. Additionally, information is available about how Siemens Remote Service for Diagnostics provides proactive customer support by optimizing system performance to enhance lab efficiency.

Multiple Siemens central lab instruments and assays are also highlighted including the compact, fully automated SysmexCA-660 System1,3 for hemostasis testing, along with the random access high-volume SysmexCS-5100 System1,3,4 coagulation analyzer, which enables first-run accuracy by identifying and managing unsuitable test specimens prior to analysis. Visitors are also getting a closer look at the CellaVisionDM96 Digital Morphology System1,5, used for automated blood cell microscopy analysis, and accessing the companys robust test menu via touch screens. Featured assays include the IMMULITE2000 Systems Anti-CCP IgG assay1 for rheumatoid arthritis, ADVIACentaur Vitamin D Total assay1,6 and Dimension VistaLOCIVitamin B12 assay1.

Emergency Room and ICU Solutions

Nearby in the Emergency Department/ICU, Siemens spotlights several of its latest near-patient critical care testing solutions, including the RAPIDLab348EX Blood Gas System1,4, a cost-effective blood gas analyzer for smaller labs that generates reliable results in approximately 60 seconds with a minimum of operator interaction. Steps away is the StratusCS Analyzer1, which delivers quantitative cardiac assays for fast patient evaluation, along with the RAPIDPoint500 Blood Gas System1 with the newly available pleural fluid pH test1.

Physicians Office and Clinic Solutions

See original here:
Siemens Shows Labs How to “Test Smarter. Run Faster.” at AACC 2013

The American Academy of Anti-aging Medicine (A4M) to Hold Four-day Continuing Medical Education Conference in Boston, MA

Posted on by

Boca Raton, FL (PRWEB) July 31, 2013

The American Board of Anti-Aging and Regenerative Medicine (ABAARM) exams will be held during this event. Also, physicians have the opportunity to sit for The American Board of Anti-Aging Health Practitioners (ABAAHP) written exam as well.

The American Academy of Anti-Aging Medicines (A4M) Fellowship in Anti-Aging and Regenerative Medicine will host several modules including Module IV: Nutrition and Metabolism; Module VIII: Lab Fundamentals and Cancer Therapies; Module XVI (C): Cardiovascular; and The Fellowship in Integrative Cancer will host Module VII: Dietary Treatments of Cancer.

Some learning objectives for Module IV include learning about nutritional depletions caused by medications, nutritions role and impact on optimal health in aging patients, new treatment plans for osteoporosis and amino acid deficiencies, and how physical, psychological and spiritual health relate to metabolic and anti-aging medicine, among other lessons.

Module VIII attendees will learn advanced integrative approaches to cancer therapies, nutritional support for athletes, how nutrients affect psychiatric illness treatments, and new protocols for advanced stage cancers.

Module XVI (C) will teach its participants nutritional and dietary therapies for prevention and treatment of cardiovascular disease, as well as sex hormone balance and function in regards to cardiovascular health in men and women, and also how nutrition plays a role in cardiovascular disease.

Cancer Module VII includes a literature review concerning diets high in Omega-6 fatty acids and the immune system, and how fat cells produce estrogen, among other topics.

The Bio-Identical Hormone Replacement Therapy Symposium (BHRT) will feature several well-known and distinguished experts in the fields of Anti-Aging and Regenerative Medicine.

Some speakers and topics include Eric Braverman, MD covering the psychological effects of BHRT and how BHRT affects the brain. Jennifer Landa, MD, OB/GYN, FAARM, will discuss sexual dysfunction and estrogen, progesterone, and testosterone therapies in peri-menopause and menopausal women. Thierry Hertoghe, MD will explain reversing the aging process with BHRT and analyzing lab tests of complicated patients. Ronald Rothenberg, MD will discuss treating adult growth hormone deficiency and will lecture on Hyperthyroidism. Director of the Fellowship on Anti-Aging and Regenerative Medicine, Pam Smith, MD, MPH, MS, will kick off the weekend with an introduction to BHRT and how BHRT solves common female health problems. Lastly, Jonathan Wright, MD will explain womens hormone replacement and adrenal fatigue, stress and cortisol.

For more information or to register for this CME event, please visit a4m.com or call 888-997-0112.

Originally posted here:
The American Academy of Anti-aging Medicine (A4M) to Hold Four-day Continuing Medical Education Conference in Boston, MA

Civil society on stem cell therapy: ‘No proof, no pay’

Posted on by

MANILA False advertising and marketing of the controversial breakthrough treatment, stem cell therapy, according to a civil society leader on Tuesday is like peddling a miracle drug to the helpless and hopeless."

Although not yet accepted as a standard method of treatment by the Department of Health (DOH), recent news abound of various surgeries performed, mostly by fly-by-night foreign doctors, charging millions of pesos for flawed outcomes.

This should not be the case, according to a coordinator of civil society group, WomanHealth Philippines, May-I Fabros, who explained in a health forum at Dulcinea, Tomas Morato on Tueday that if the treatment had little proof of its safety, doctors or institutions are in no position to require any form of compensation.

Fabros explained that patients or consumers have rights in the advent of stem cell therapy and have every right to be educated on both the benefits and detriments of the treatment to health.

When a doctor tells a family member or relative of a sick patient that all methods to treat him or her have failed but stem cell therapy might be able to help, that person will clutch on that hope, Fabros said.

For us Filipinos, nothing is too expensive for family, she added, explaining how for all classes, they would give every cent they just to get their loved ones well again. The objective is to have them live.

She explained that this affects the poor, especially as they would even go as far as selling land, property and every bit of their being to avail of a treatment that might cause a person more harm than good.

You should not pay if its not effective, Fabros said. Until proven it should not be for sale. (PNA)

PDS/ANP

For the latest Zamboanga City and Philippine news stories and videos, visit ZamboTimes.com

Read more:
Civil society on stem cell therapy: 'No proof, no pay'

Methamphetamine increases susceptibility to deadly fungal infection

Posted on by

Public release date: 30-Jul-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

Methamphetamine use can make a person more susceptible to the lung infection cryptococcosis, according to a study published in mBio, the online open-access journal of the American Society for Microbiology.

Researchers found that injected methamphetamine (METH) significantly enhanced colonization of the lungs by Cryptococcus neoformans and accelerated progression of the disease and the time to death in mouse models. C. neoformans is usually harmless to healthy individuals, but METH causes chinks in the blood-brain barrier that can permit the fungus to invade the central nervous system, where it causes a deadly brain infection.

"The highest uptake of the drug is in the lungs," says corresponding author Luis Martinez of Long Island University-Post, in Brookville, New York and of Albert Einstein College of Medicine in The Bronx. "This may render the individual susceptible to infection. We wanted to know how METH would alter C. neoformans infection."

Thirteen million people in the US have abused METH in their lifetimes, and regular METH users numbered approximately 353,000 in 2010, the most recent year for which data are available. A central nervous system stimulant that adversely impacts immunological responses, recent studies show that injected METH accumulates in various sites in the body, but the lungs seem to accumulate the highest concentrations, says Martinez, which could well impact how the lung responds to invading pathogens.

To study the impact this accumulation might have on pulmonary infection, Martinez and his colleagues injected mice with doses of METH over the course of three weeks, then exposed those mice to the C. neoformans fungus. In humans, C. neoformans initially infects the lungs but often crosses the blood-brain barrier to infect the central nervous system and cause meningitis. In their experiments, METH significantly accelerated the speed with which the infected mice died, so that nine days after infection, 100% of METH treated mice were dead, compared to 50% of the control mice.

Using fluorescent microscopy to examine lung tissue in METH-treated and control mice, the researchers found that METH enhanced the interaction of C. neoformans with epithelial cells in the lining of the lung. Seven days after exposure to the fungus, the lungs of METH-treated mice showed large numbers of fungi surrounded by vast amounts of gooey polysaccharide in a biofilm-like arrangement. METH-treated mice also displayed low numbers of inflammatory cells early during infection and breathed faster than controls, a sign of respiratory distress.

Martinez says this greater ability to cause disease in the lung may be due in part to simple electrical attraction. Their analysis shows that METH imparts a greater negative charge on the surface of the fungal cells, possibly lending them a greater attraction to the surface of the lung and an enhanced ability to form a biofilm that can protect its members from attack by the immune system. The fungus also releases more of its capsular polysaccharide in METH-treated mice, which can help the organism colonize and persist in the lung.

"When the organism senses the drug, it basically modifies the polysaccharide in the capsule. This might be an explanation for the pathogenicity of the organism in the presence of the drug, but it also tells you how the organism senses the environment and that it will modify the way that it causes disease," Martinez says.

More here:
Methamphetamine increases susceptibility to deadly fungal infection

Genetic engineering may the only thing that can save the world’s oranges

Posted on by

Genetic engineering may save the orange tree from becoming an endangered speciesThere's a virulent disease destroying orange trees around the world, and growers are facing a hard choice genetically engineer the orange to survive this plague, or possibly see the fruit, and their livelihood, disappear.

The effects of Citrus GreeningThe disease, called Citrus Greening (or Huanglongbing or yellow dragon disease), is a bacteria that was first reported in China in the early 20th century, and it's spread by tiny insects called Asian citrus psyllids. Orange trees infected by this bacteria drop their leaves, and their fruit becomes stunted. There's no pesticide that can control the psyllids that carry the disease (they quickly adapted to the ones we have), and there's no treatment for the disease itself. The only way to 'treat' an infection is to quarantine the area and burn the infected trees. However, even those efforts aren't helping much. This disease has spread throughout the southern United States, Mexico and Central America, Brazil, southeast Asia and western Africa, threatening crops from the largest orange producers in the world.

[ Related: GMO companies launch website to fight anti-biotech movement ]

One source of hope, it seems, is genetic engineering.

According to a New York Times article from this past weekend (which I highly recommend reading), growers in Florida have been looking into genetic engineering since 2005, but despite some promising results so far, they are understandably worried about public reaction.

Genetically-modified organisms 'GMOs' have a very bad reputation with the public these days. It's hard to even mention them without someone speaking of the evils of Monsanto, or hearing the word 'frankenfood', or about how genetically-modified foods cause any number of illnesses and diseases. Given that it's our health and our lives that we're talking about, being concerned about what we're being given to eat is understandable.

However, historically, we've been genetically modifying our crops and livestock for centuries, if not millennia. It's been done through cross-breeding and cross-pollination, with mixed results. The point is, though, that it's very unlikely that anything we eat these days has gone without some kind of human manipulation at some point. New techniques of directly changing the DNA of the plant or animal cause more concerns, though, with talk of splicing in animal DNA into plants.

Take it from a self-proclaimed hippy who thinks Monsanto is evil, though, that's not what scientists are doing. They create artificial genes based on what they see in animal genes, rather than splicing animal genes directly into plant DNA. That may not help someone's perception of what's going on, since it still impacts how 'natural' a food is, but in that case, I'll simply point back to the start of the previous paragraph. Also, another point this 'hippy' makes is that the more 'natural' cross-breeding methods are no safer than directly altering DNA (in fact, the more direct method is the safer of the two).

The science speaks on behalf of GMOs as well. The American Association for the Advancement of Science wrote last October that "the World Health Organization, the American Medical Association, the U.S. National Academy of Sciences, the British Royal Society, and 'every other respected organization that has examined the evidence has come to the same conclusion: consuming foods containing ingredients derived from GM crops is no riskier than consuming the same foods containing ingredients from crop plants modified by conventional plant improvement techniques.'"

[ More Geekquinox: U.S. supercomputer now doubles power for hurricane forecasts ]

See more here:
Genetic engineering may the only thing that can save the world’s oranges

The American Academy of Anti-Aging Medicine (A4M) to host Gut, Brain, and Autoimmune Disorders: the Role of Food …

Posted on by

Boca Raton, FL (PRWEB) July 30, 2013

A4Ms Gut, Brain, and Autoimmune Disorders Symposium will take place August 16-17 at the JW Marriott- LA Live, in Los Angeles, CA. This two-day meeting is worth 15.5 CME credits and will provide attendees with the most up-to-date information and educational materials regarding the links between food and disease manifestations, GI and neurological disorders, as well as the effects that food related disorders have on major organ systems in the body.

After completing this course, practitioners will understand the connections between the GI and nervous systems, diagnostic tests and clinical tools, and new areas of research.

The weekend conference features expert and well-known speakers including William Davis, MD, Alessio Fasano, MD, and David Perlmutter, MD, FACN, ABIHM, among others.

Some of the presentations covered will include Role of Food Sensitivity and Bowel Disease, New Concepts of Celiac Disease, Wheat: The Unhealthy Grain, and The Leading Edge of Functional Neurology.

Dr. Davis is a cardiologist, author of a New York Times Bestseller, and Medical Director and founder of the Track Your Plaque program for prevention and reversal of heart disease. Dr. Fasano serves as Division Chief of Pediatric Gastroenterology and Nutrition at Mass General Hospital for Children. Dr. Perlmutter is a Board Certified Neurologist, Fellow of the American College of Nutrition, and Medical Director of the Perlmutter Health and Hyperbaric Centers in Naples, Florida.

Every medical professional can improve their patients well-being by attending this symposium. Please visit our website to learn more about Gut, Brain and Autoimmune Disorders.

Read this article:
The American Academy of Anti-Aging Medicine (A4M) to host Gut, Brain, and Autoimmune Disorders: the Role of Food ...

Genetic Engineering: A New Use for Algae in Biofuel Production

Posted on by

Lawrence, KS (PRWEB) July 29, 2013

Phycologia In recent years major companies from all over the globe, including Exxon Mobile and Itochu Corporation, have merged with research facilities to research algae as a renewable energy source. However, it has been determined that far more research is needed before movement to the commercial production phase of algae biofuel can truly take place. A recent research study took up this challenge and examined a promising freshwater algal strain for possible genetic engineering applications that could make it a viable biofuel.

An article in the journal Phycologia takes an in-depth look at the genetic structure of a unicellular green alga, Botryococcus braunii, and explores its unique ability to be utilized in the genetic engineering of biofuel development. Botryococcus braunii was initially selected for large-scale biofuel production because of its extraordinary ability to synthesize large amounts of hydrocarbon oils. Several difficulties were encountered in the initial production and harvesting processes, leaving it by the wayside. However, this latest research reintroduces B. braunii as the perfect vehicle for genetic engineering applications when compared with three other species of green algae, five species of land plants, and eight other phyla species, including bacteria, archaea, fungi, and mammals.

The research focused on the codon usage, or DNA compatibility, of B. braunii with the other organisms. Codon usage for this particular alga is one of the fundamental genetic markers that had not been explored. Codons are greatly affected by the vast amount of guanines (G) and cytosines (C), two of the four nucleotides that make up a DNA molecule. Many green algal species having high GC content, which causes codon usage bias, or poor compatibility, with other organisms. Surprisingly, B. braunii had comparatively low GC content and its codon usage was similar to that of bacteria, mammals, and land plants.

Although further study is necessary, the ability of B. braunii to synthesize hydrocarbons, combined with the newly discovered codon usage and GC content data, could lead to new genetic engineering techniques that could hasten biofuel development and production.

Full text of the article, Codon usage of Botryococcus braunii (Trebouxiophyceae, Chlorophyta): implications for genetic engineering applications, Phycologia, Vol. 52, No. 4, 2013, is available at http://www.phycologia.org/doi/full/10.2216/12-041.1

About Phycologia Phycologia is the official publication of the International Phycological Society and publishes papers on any aspect of algal research. For more information, visit http://www.intphycsoc.org.

Read more:
Genetic Engineering: A New Use for Algae in Biofuel Production